Global Automated Antimicrobial Susceptibility Testing Market, By Product Type (Consumables and Instruments), By Detection Method (Turbidimetric and Colorimetric), By Application (Antibacterial (Tuberculosis and Sepsis), Antifungal, Anti-parasitic, and Anti-viral), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, and Pathology/Diagnostic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 1,295.5 million in 2018 and is projected to exhibit a CAGR of 8.9% over the forecast period (2018 – 2026), as highlighted in a new report published by.
Increasing multidrug resistance research, new product launches, and rising number of development programs and funding among others are major factors that are expected to drive growth of the automated antimicrobial susceptibility testing market.
Get Exclusive FREE Sample Copy of “Automated Antimicrobial Susceptibility Testing Market” Report @ https://www.coherentmarketinsights.com/insight/request-sample/2622
Contract research organizations perform various research and development activities involving AST and multidrug resistivity testing. Increasing research and development of small molecules by various manufacturing organizations is expected to increase the adoption of AST during the forecast period. For instance, according to Cambrex Corporation’s report 2017 on small molecules, small molecules are expected to gain major traction in the pharmaceutical industry, with the approval of 34 new small molecule entities by the U.S. Food and Drug Administration (FDA) in 2017.
Key players are engaged in launching susceptibility testing systems in the market, in order to expand its product portfolio. For instance, in March 2016, Thermo Fisher Scientific launched antimicrobial susceptibility testing for Tedizolid, enabling microbiology laboratories to perform Tedizolid susceptibility testing of fastidious and non-fastidious Gram positive organisms, which cause acute bacterial skin and skin structure infections (ABSSSIs) in adults. Increasing launch of such AST testing could result in increasing adoption of susceptibility plates during the forecast period.
Moreover, in 2017, bioMérieux launched ETEST Ceftolozane/Tazobactam and ETEST Ceftazidime/Avibactam, which determines the minimum inhibitory concentration (MIC) values necessary to effectively treat infections caused by multidrug resistant organisms.
Browse 38 Market Data Tables and 25 Figures spread through 200 Pages and in-depth TOC on “Automated Antimicrobial Susceptibility Testing Market, By Product Type (Consumables and Instruments), By Detection Method (Turbidimetric and Colorimetric), By Application (Antibacterial (Tuberculosis and Sepsis), Antifungal, Anti-parasitic, and Anti-viral), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, and Pathology/Diagnostic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026”
To know the latest trends and insights related to automated antimicrobial susceptibility testing market Press Release, click the link below: https://www.coherentmarketinsights.com/press-release/automated-antimicrobial-susceptibility-testing-market-to-surpass-us-25549-million-by-2026-1397
Rising funding for research of antibiotic-resistant microbes is expected to boost the automated antimicrobial susceptibility testing market revenue over the forecast period. For instance, in November 2017, Symcel AB, a company engaged in cell-based assay tool for real-time cell metabolism measurements, secured US$ 4.23 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.
Key Takeaways of the Automated Antimicrobial Susceptibility Testing Market:
- The global automated antimicrobial susceptibility testing market is expected to witness a CAGR of 8.9% during the forecast period (2018–2026), owing to increasing research & development and demand for genomic and repertoire sequencing-based research
- Among product type, the consumables segment is expected to hold major revenue share in 2026, owing to increasing product launches. For instance, in 2016, HiMedia Laboratories introduced its HiCrome Muller Hinton Agar product, which is used for presumptive identification and susceptibility testing.
- Major players operating in the global automated antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.
Get your Customized Research Report: https://www.coherentmarketinsights.com/insight/request-customization/2622
Detailed Segmentation:
- Global Automated Antimicrobial Susceptibility Testing Market, By Product Type:
- Consumables
- Instruments
- Global Automated Antimicrobial Susceptibility Testing Market, By Detection Method:
- Turbidimetric
- Colorimetric
- Global Automated Antimicrobial Susceptibility Testing Market, By Application:
- Antibacterial
- Tuberculosis
- Sepsis
- Antifungal
- Anti-parasitic
- Anti-viral
- Antibacterial
- Global Automated Antimicrobial Susceptibility Testing Market, By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Hospitals
- Pathology/Diagnostic Laboratories
- Global Automated Antimicrobial Susceptibility Testing Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- By Product Type:
- Consumables
- Instruments
- By Detection Method:
- Turbidimetric
- Colorimetric
- By Application:
- Antibacterial
- Tuberculosis
- Sepsis
- Antifungal
- Anti-parasitic
- Anti-viral
- Antibacterial
- By End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Hospitals
- Pathology/Diagnostic Laboratories
- By Country:
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Product Type:
- By Detection Method:
- By Application:
- By End User:
- By Country:
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Product Type:
- By Detection Method:
- By Application:
- By End User:
- By Country:
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type:
- By Detection Method:
- By Application:
- By End User:
- By Country:
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type:
- By Detection Method:
- By Application:
- By End User:
- By Country:
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Product Type:
- By Detection Methods:
- By Application:
- By End User:
- By Country/Region:
- North America
- Company Profiles
- bioMérieux S.A.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- HiMedia Laboratories
- Alifax Holding S.p.A.
- Creative Diagnostics
- Resistell AG
- Danaher Corporation
- Becton, Dickinson, and Company
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- bioMérieux S.A.*
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
sales@coherentmarketinsights.com
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737